Vital Therapies reported $-56474000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Dynavax Technologies DVAX:US USD 67.97M 3.88M
Enanta Pharmaceuticals ENTA:US USD -29020000 2.69M
Insmed INSM:US USD -159998000 29.22M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Omeros OMER:US USD -46048000 8.74M
Orasure Technologies OSUR:US USD 15.4M 11.26M
Regulus Therapeutics RGLS:US USD -6795000 756K
Revance Therapeutics RVNC:US USD -145952000 61.96M
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M
United Therapeutics UTHR:US USD 178.8M 133.7M
Vital Therapies VTL:US USD -56474000 35.25M
Xoma XOMA:US USD -5894000 1.72M